When Thyroid Carcinoma Goes Bad: A Morphological and Molecular Analysis

被引:43
作者
Papp S. [1 ,2 ]
Asa S.L. [1 ,2 ]
机构
[1] Department of Pathology, Laboratory Medicine Program, University Health Network, 200 Elizabeth Street, 11th Floor, Toronto, M5G 2C4, ON
[2] Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON
关键词
Angioinvasion; Epigenetics; Mutations; Rearrangements; Thyroid carcinoma;
D O I
10.1007/s12105-015-0619-z
中图分类号
学科分类号
摘要
Thyroid carcinomas of follicular epithelial derivation are common and generally well-behaved malignancies with excellent cure and survival rates. However, a subset of these carcinomas, whether well-differentiated, poorly differentiated, or anaplastic, is highly aggressive, manifesting with local invasion, recurrence, and distant metastasis. The recognition of dedifferentiation is of paramount importance. In addition, the challenge for Pathologists is to identify the rare aggressive differentiated carcinomas so that treatment may be tailored appropriately. Thus, histological subtyping and documentation of other aggressive features such as widespread invasion and angioinvasion are critical. Mutational analyses in the past decade have delineated the molecular alterations responsible for thyroid carcinogenesis and progression, allowing greater sub-classification and prognostication of thyroid carcinomas. This review article highlights important aggressive morphologic features and molecular mutations associated with thyroid carcinoma. © 2015, Springer Science+Business Media New York.
引用
收藏
页码:16 / 23
页数:7
相关论文
共 33 条
[1]  
Albores-Saavedra J., Henson D.E., Glazer E., Et al., Changing patterns in the incidence and survival of thyroid cancer with follicular phenotype–papillary, follicular, and anaplastic: a morphological and epidemiological study, Endocr Pathol, 18, pp. 1-7, (2007)
[2]  
O'Neill C.J., Oucharek J., Learoyd D., Et al., Standard and emerging therapies for metastatic differentiated thyroid cancer, Oncologist, 15, pp. 146-156, (2010)
[3]  
Mete O., Asa S.L., Pathological definition and clinical significance of vascular invasion in thyroid carcinomas of follicular epithelial derivation, Mod Pathol, 24, pp. 1545-1552, (2011)
[4]  
Brierley J.D., cancer A.S.L.T., Gospodarowicz M.K., O'Sullivan B., Sobin L., Chapter 11, Prognostic factors in cancer, pp. 119-122, (2006)
[5]  
The Cancer Genome Atlas ResearchNetwork, Integrated genomic characterization of papillary thyroid carcinoma, Cell, 159, pp. 676-690, (2014)
[6]  
D'Avanzo A., Treseler P., Ituarte P.H.G., Et al., Follicular thyroid carcinoma: histology and prognosis, Cancer, 100, pp. 1123-1129, (2004)
[7]  
Cheng S., Serra S., Mercado M., Et al., A high-throughput proteomic approach provides distinct signatures for thyroid cancer behavior, Clin Cancer Res, 17, pp. 2385-2394, (2011)
[8]  
Asioli S., Erickson L.A., Sebo T.J., Et al., Papillary thyroid carcinoma with prominent hobnail features: a new aggressive variant of moderately differentiated papillary carcinoma. A clinicopathologic, immunohistochemical, and molecular study of eight cases, Am J Surg Pathol, 34, pp. 44-52, (2010)
[9]  
Ghossein R., Encapsulated malignant follicular cell-derived thyroid tumors, Endocr Pathol, 21, pp. 212-218, (2010)
[10]  
Zhu Z., Gandhi M., Nikiforova M.N., Et al., Molecular profile and clinical-pathologic features of the follicular variant of papillary thyroid carcinoma. An unusually high prevalence of RAS mutations, Am J Clin Pathol, 120, pp. 71-77, (2003)